title: [What can be expected of intracavernous injections?].
authors.forename: A
authors.initials: A
authors.lastname: Jardin
authors.forename: H
authors.initials: H
authors.lastname: Bensadoun
authors.forename: G
authors.initials: G
authors.lastname: Benoit
authors.forename: A
authors.initials: A
authors.lastname: Puech
authors.forename: L
authors.initials: L
authors.lastname: Alexandre
mesh_terms: D000328:Adult; D000368:Aged; D001058:Apomorphine / Q000008:administration & dosage / Q000494:pharmacology; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000379:methods; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D013948:Moxisylyte / Q000494:pharmacology; D010208:Papaverine / Q000008:administration & dosage / Q000494:pharmacology*; D010413:Penis / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D014665:Vasodilator Agents; D010208:Papaverine; D001058:Apomorphine; D013948:Moxisylyte
vernacular_title: Que peut-on attendre des injections intra-caverneuses?